« Diabetes Expert Writes Gripping Mystery About Diabetic P.I. | Main | The Staggering Rise of Type 1 Diabetes »
March 15, 2007
Promising New Anti-cancer Treatment Approved For HER2-Positive Breast Cancer
The FDA has approved Tykerb (lapatinib), a new targeted anti-cancer treatment that is significantly more effective than current medicines in fighting advanced stage of breast cancer, for use in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein): The combination treatment is indicated for women who have received prior therapy with other cancer drugs, including an anthracycline, a taxane, and trastuzumab (Herceptin). According to the American Cancer Society, about 180,000 new cases of breast cancer are diagnosed each year. Approximately 8,000 to 10,000 women die from metastatic HER2 positive breast cancer each year.
Posted by Diabetologica at March 15, 2007 7:56 PM